As this method is general, we anticipate that it could be applied to other amyloid fibrils implicated in neurodegenerative diseases, including tau (Alzheimer’s disease), huntingtin (Huntington’s disease), TDP-43 (ALS), and α-synuclein (Parkinson’s disease). This evidence concerns the gene MAPT and juvenile Huntington disease.